Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients

The use of 20% subcutaneous immunoglobulin replacement therapy in patients with B cell non-Hodgkin’s lymphoma with humoral immune dysfunction after treatment with rituximab.

(2020) S Shahzad Mustafa et al.   Clinical Lymphoma Myeloma & Leukemia

Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study

(2020) Patricia Richi et al.   CLINICAL RHEUMATOLOGY

Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis

(2020) Derek K Chu et al.   LANCET

Factors associated with COVID-19-related death using OpenSAFELY

(2020) Elizabeth J. Williamson et al.   NATURE

Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study

(2020) Amit Bar-Or et al.   NEUROLOGY

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

(2020) Abi Vijenthira et al.   BLOOD

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases—a prospective multi-centre cohort study

(2019) S Bühler et al.   RHEUMATOLOGY

Depletion of B cells rejuvenates the peripheral B‐cell compartment but is insufficient to restore immune competence in aging

(2019) Irit Avivi et al.   AGING CELL

Antibody responses to influenza vaccine in patients on biological therapy: Results of RIER cohort study

(2019) Patricia Richi et al.   MEDICINA CLINICA

Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome

(2019) Manuela Colucci et al.   Frontiers in Immunology

RoB 2: a revised tool for assessing risk of bias in randomised trials

(2019) Jonathan A C Sterne et al.   BMJ-British Medical Journal

Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies

(2017) Janie Parrino et al.   VACCINE

Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients

(2016) Daryl R Cheng et al.   Expert Review of Vaccines

Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies

(2015) Gunjan L. Shah et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The response to vaccination against influenza A(H1N1) 2009, seasonal influenza andStreptococcus pneumoniaein adult outpatients with ongoing treatment for cancer with and without rituximab

(2014) Åke Berglund et al.   ACTA ONCOLOGICA

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis

(2014) Meliha C Kapetanovic et al.   ARTHRITIS RESEARCH & THERAPY

Immunogenicity of a monovalent influenza A(H1N1)pdm09 vaccine in patients with hematological malignancies

(2014) Yuichiro Ide et al.   Human Vaccines & Immunotherapeutics

A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function

(2013) E. G. Kamburova et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The effect of rituximab on vaccine responses in patients with immune thrombocytopenia

(2013) I. Nazi et al.   BLOOD

Reduced antibody formation after influenza vaccination in patients with neuromyelitis optica spectrum disorder treated with rituximab

(2013) W. Kim et al.   EUROPEAN JOURNAL OF NEUROLOGY

Meta-analysis of prevalence

(2013) Jan J Barendregt et al.   JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH

Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

(2013) Charlotte Hua et al.   ARTHRITIS CARE & RESEARCH

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis

(2013) Meliha Crnkic Kapetanovic et al.   ARTHRITIS RESEARCH & THERAPY

Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens

(2012) D. Bedognetti et al.   BLOOD

Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology

(2012) Jordan S. Orange et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination

(2012) Robert A. Eisenberg et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Evaluation of 2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies receiving chemotherapy or following autologous stem cell transplant

(2012) Diego Villa et al.   LEUKEMIA & LYMPHOMA

A Prospective Study of the Factors Shaping Antibody Responses to the AS03-Adjuvanted Influenza A/H1N1 Vaccine in Cancer Outpatients

(2012) A. F. Hottinger et al.   ONCOLOGIST

Viral Infections in Immunocompromised Hosts

(2012) Mageshbabu Ramamurthy et al.   Proceedings of the National Academy of Sciences, India. Section B

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment

(2011) O. E. Yri et al.   BLOOD

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia

(2011) S. Audia et al.   BLOOD

Effect of rituximab on human in vivo antibody immune responses

(2011) Mark D. Pescovitz et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Impaired Response to Influenza Vaccine Associated with Persistent Memory B Cell Depletion in Non-Hodgkin's Lymphoma Patients Treated with Rituximab-Containing Regimens

(2011) D. Bedognetti et al.   JOURNAL OF IMMUNOLOGY

The pandemic H1N1 influenza vaccine results in low rates of seroconversion for patients with hematological malignancies

(2011) Katherine Monkman et al.   LEUKEMIA & LYMPHOMA

The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab

(2011) U. Arad et al.   VACCINE

Seroprotective Titers against 2009 H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

(2010) Nicolas C. Issa et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases

(2010) Nichola Cooper et al.   BRITISH JOURNAL OF HAEMATOLOGY

Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies

(2010) A. WONG et al.   EPIDEMIOLOGY AND INFECTION

Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host

(2010) H. de Lavallade et al.   HAEMATOLOGICA

Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment

(2010) Helen J. Mackay et al.   JOURNAL OF CLINICAL VIROLOGY

Good and bad memories following rituximab therapy

(2009) E. William St.Clair   ARTHRITIS AND RHEUMATISM

Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial

(2009) Clifton O. Bingham et al.   ARTHRITIS AND RHEUMATISM

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

(2009) Sander van Assen et al.   ARTHRITIS AND RHEUMATISM

Pertussis Immunity and Response to Tetanus-Reduced Diphtheria-Reduced Pertussis Vaccine (Tdap) after Autologous Peripheral Blood Stem Cell Transplantation

(2009) Trudy N. Small et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

B Cell Survival in Intragraft Tertiary Lymphoid Organs After Rituximab Therapy

(2009) Olivier Thaunat et al.   TRANSPLANTATION

Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response

(2009) Magda Nakou et al.   ARTHRITIS RESEARCH & THERAPY

Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus

(2008) D Albert et al.   ANNALS OF THE RHEUMATIC DISEASES

The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells

(2008) M. Mamani-Matsuda et al.   BLOOD

Maintenance of the plasma cell pool is independent of memory B cells

(2008) A. Ahuja et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA